BioSpace News Archive

BioCapital

ACRO, Congressional R&D Caucus Host Congressional Briefing on Clinical Research Advancements

On October 23, the Association of Clinical Research Organizations and the Congressional Research & Development Caucus hosted a Congressional Briefing on Capitol Hill about the advancements clinical research and technology companies are making in drug development.

October 28, 2019
·
2 min read
Job Trends

DaVita Health Solutions Becomes Vively Health™

Vively embodies company’s mission to deliver innovative, comprehensive care to the highest risk patients managing multiple chronic conditions

October 28, 2019
·
2 min read
Drug Development

IVERIC bio’s Zimura®, a Novel Complement C5 Inhibitor, Met its Primary Endpoint and Reached Statistical Significance in a Phase 2b Randomized, Controlled Clinical Trial in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Overall Data Suggest a Dose Response Relationship Across Treatment Groups

October 28, 2019
·
10 min read
Business

DarioHealth Reports Results for Third Quarter 2019

Global digital therapeutics innovator DarioHealth Corp., reported financial and operational results for the third quarter ended September 30, 2019.

October 28, 2019
·
14 min read
Business

PLx Pharma Inc. to Discuss 2019 Third Quarter Financial Results on November 8, 2019 Conference Call

PLx Pharma Inc. announced that the Company will release its 2019 third quarter financial results on Friday, November 8, 2019, before the U.S. financial markets open.

October 28, 2019
·
2 min read
Job Trends

Myriad Genetics to Present Seven Studies at the 2019 National Society of Genetic Counselors Annual Meeting

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that it will present results from seven studies at the 2019 National Society of Genetic Counselors annual meeting being held Nov. 5–8, 2019 in Salt Lake City.

October 28, 2019
·
8 min read
Drug Development

BioCryst Reports Data From Phase 1 Trial of BCX9930 and Announces Plans to Advance Program Into Proof of Concept Study in PNH Patients

Phase 1 data showed rapid, sustained and >95% inhibition of alternative pathway of complement system with 100 mg of oral BCX9930 BID

October 28, 2019
·
7 min read
Pharm Country

Axsome Therapeutics Announces Continued Progress in Clinical Development of AXS-07 for the Acute Treatment of Migraine

Enrollment in MOMENTUM Phase 3 migraine trial of AXS-07 in patients with history of inadequate response nearly complete; on track for topline results in 4Q 2019

October 28, 2019
·
12 min read
Drug Development

TG Therapeutics Announces Positive Results from the UNITY-NHL Phase 2b Pivotal Trial Evaluating Umbralisib Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma

Follicular lymphoma cohort met the primary endpoint of overall response rate (ORR)

October 28, 2019
·
7 min read
Pharm Country

Axsome Therapeutics Announces Results of MINDSET Physician Survey Affirming Unmet Need and Favorable Profile of AXS-07 in the Acute Treatment of Migraine

Majority of physicians would be more likely to prescribe AXS-07 over current and other emerging treatments if AXS-07 efficacy is confirmed in ongoing MOMENTUM Phase 3 trial

October 28, 2019
·
11 min read